AIM IMMUNOTECH INC. Long-Term Debt, Maturity, Year Two
AIM IMMUNOTECH INC. (AIM) had Long-Term Debt, Maturity, Year Two of $588.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2026-08-07
- 2026-03-31: Long-Term Debt, Maturity, Year Two $588.00K.
- 2025-12-31: Long-Term Debt, Maturity, Year Two $927.00K.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2026-03-31 | $588.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $927.00K 10-Q · filed 2026-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |